FDA Approves Eli Lilly's Foundayo Oral Weight-Loss Pill

The FDA has approved Eli Lilly's Foundayo, a once-daily oral GLP-1 weight-loss drug, marking the second such pill after Novo Nordisk's Wegovy. It offers flexible dosing and aims to improve accessibility for obesity treatment.

NHS Offers Weight-Loss Drug to 1.2M for Heart Health

NHS England expands access to semaglutide, offering weekly injections to 1.2 million overweight individuals at risk of heart attacks and strokes, following clinical trials showing cardiovascular benefits.

UK Government Screen Time Guidance for Under-Fives

New UK government advice recommends no more than one hour of daily screen time for children under five, with under-twos advised against solo screen use. Parents share their experiences and challenges.

Experts Warn Against Unregulated Injectable Peptides Online

Injectable peptides, promoted by influencers as a 'glow up potion' for various health issues, are not approved for human use and pose serious risks, warn medical experts. Unregulated online sales and unverified claims amplify dangers.

Page 51 of 205
Pickt mobile sticky banner — logo, tagline and CTA button